281 related articles for article (PubMed ID: 27818939)
1. Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity.
Tardelli M; Zeyda K; Moreno-Viedma V; Wanko B; Grün NG; Staffler G; Zeyda M; Stulnig TM
Mol Metab; 2016 Nov; 5(11):1131-1137. PubMed ID: 27818939
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin affects macrophage polarization promoting endocytic but not inflammatory properties.
Schuch K; Wanko B; Ambroz K; Castelo-Rosa A; Moreno-Viedma V; Grün NG; Leitner L; Staffler G; Zeyda M; Stulnig TM
Obesity (Silver Spring); 2016 Jul; 24(7):1489-98. PubMed ID: 27221527
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.
Nomiyama T; Perez-Tilve D; Ogawa D; Gizard F; Zhao Y; Heywood EB; Jones KL; Kawamori R; Cassis LA; Tschöp MH; Bruemmer D
J Clin Invest; 2007 Oct; 117(10):2877-88. PubMed ID: 17823662
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations.
Kiefer FW; Zeyda M; Todoric J; Huber J; Geyeregger R; Weichhart T; Aszmann O; Ludvik B; Silberhumer GR; Prager G; Stulnig TM
Endocrinology; 2008 Mar; 149(3):1350-7. PubMed ID: 18048491
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function.
Zeyda M; Gollinger K; Todoric J; Kiefer FW; Keck M; Aszmann O; Prager G; Zlabinger GJ; Petzelbauer P; Stulnig TM
Endocrinology; 2011 Jun; 152(6):2219-27. PubMed ID: 21467192
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice.
Chapman J; Miles PD; Ofrecio JM; Neels JG; Yu JG; Resnik JL; Wilkes J; Talukdar S; Thapar D; Johnson K; Sears DD
PLoS One; 2010 Nov; 5(11):e13959. PubMed ID: 21103061
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance.
Kiefer FW; Zeyda M; Gollinger K; Pfau B; Neuhofer A; Weichhart T; Säemann MD; Geyeregger R; Schlederer M; Kenner L; Stulnig TM
Diabetes; 2010 Apr; 59(4):935-46. PubMed ID: 20107108
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice.
Lancha A; Rodríguez A; Catalán V; Becerril S; Sáinz N; Ramírez B; Burrell MA; Salvador J; Frühbeck G; Gómez-Ambrosi J
PLoS One; 2014; 9(5):e98398. PubMed ID: 24871103
[TBL] [Abstract][Full Text] [Related]
9. The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue.
Liu LF; Kodama K; Wei K; Tolentino LL; Choi O; Engleman EG; Butte AJ; McLaughlin T
Diabetologia; 2015 Jul; 58(7):1579-86. PubMed ID: 25952479
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity.
Bertola A; Deveaux V; Bonnafous S; Rousseau D; Anty R; Wakkach A; Dahman M; Tordjman J; Clément K; McQuaid SE; Frayn KN; Huet PM; Gugenheim J; Lotersztajn S; Le Marchand-Brustel Y; Tran A; Gual P
Diabetes; 2009 Jan; 58(1):125-33. PubMed ID: 18952835
[TBL] [Abstract][Full Text] [Related]
11. Local proliferation initiates macrophage accumulation in adipose tissue during obesity.
Zheng C; Yang Q; Cao J; Xie N; Liu K; Shou P; Qian F; Wang Y; Shi Y
Cell Death Dis; 2016 Mar; 7(3):e2167. PubMed ID: 27031964
[TBL] [Abstract][Full Text] [Related]
12. 4-1BBL signaling promotes cell proliferation through reprogramming of glucose metabolism in monocytes/macrophages.
Tu TH; Kim CS; Nam-Goong IS; Nam CW; Kim YI; Goto T; Kawada T; Park T; Yoon Park JH; Ryoo ZY; Park JW; Choi HS; Yu R
FEBS J; 2015 Apr; 282(8):1468-80. PubMed ID: 25691217
[TBL] [Abstract][Full Text] [Related]
13. Does osteopontin induce adipose tissue inflammation by local macrophage proliferation?
Kahles F; Findeisen HM
Mol Metab; 2016 Dec; 5(12):1147-1148. PubMed ID: 27900257
[No Abstract] [Full Text] [Related]
14. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation.
Zhuang G; Meng C; Guo X; Cheruku PS; Shi L; Xu H; Li H; Wang G; Evans AR; Safe S; Wu C; Zhou B
Circulation; 2012 Jun; 125(23):2892-903. PubMed ID: 22580331
[TBL] [Abstract][Full Text] [Related]
15. Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.
Grün NG; Strohmeier K; Moreno-Viedma V; Le Bras M; Landlinger C; Zeyda K; Wanko B; Leitner L; Staffler G; Zeyda M; Stulnig TM
Immunol Lett; 2016 Nov; 179():85-94. PubMed ID: 27639826
[TBL] [Abstract][Full Text] [Related]
16. Targeting ERβ in Macrophage Reduces Crown-like Structures in Adipose Tissue by Inhibiting Osteopontin and HIF-1α.
Wang L; Zhao RP; Song XY; Wu WF
Sci Rep; 2019 Oct; 9(1):15762. PubMed ID: 31673032
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity.
Lu C; Kumar PA; Sun J; Aggarwal A; Fan Y; Sperling MA; Lumeng CN; Menon RK
J Biol Chem; 2013 May; 288(22):15725-35. PubMed ID: 23595986
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
Finucane OM; Reynolds CM; McGillicuddy FC; Harford KA; Morrison M; Baugh J; Roche HM
PLoS One; 2014; 9(11):e113369. PubMed ID: 25412423
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice.
Kiefer FW; Neschen S; Pfau B; Legerer B; Neuhofer A; Kahle M; Hrabé de Angelis M; Schlederer M; Mair M; Kenner L; Plutzky J; Zeyda M; Stulnig TM
Diabetologia; 2011 Aug; 54(8):2132-42. PubMed ID: 21562757
[TBL] [Abstract][Full Text] [Related]
20. Immunological blockade of adipocyte inflammation caused by increased matrix metalloproteinase-cleaved osteopontin in obesity.
Leitner L; Schuch K; Jürets A; Itariu BK; Keck M; Grablowitz V; Aszmann OC; Prager G; Staffler G; Zeyda M; Stulnig TM
Obesity (Silver Spring); 2015 Apr; 23(4):779-85. PubMed ID: 25776538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
